Conservative management of patients with cerebrospinal fluid shunt infections

Neurosurgery

Volumn 58, Issue 4, 2006, Pages 657-664

  Brown, Erwin M ^a   Edwards, Richard J ^a   Pople, Ian K ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Adverse event; Infection; Outpatient therapy; Ventricular access device; Ventriculoperitoneal shunt

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONSERVATIVE TREATMENT; DEATH; FOLLOW UP; HUMAN; INFANT; INFECTION; MEDICAL LITERATURE; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; TIME SERIES ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; HUMANS; INFANT; INJECTIONS, INTRAVENTRICULAR; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES;

EID: 33645761176     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000204126.54417.46     Document Type: Article

References (47)

1. Aquilina K, Edwards RJ, Pople IK: Routine placement of a ventricular reservoir at endoscopic third ventriculostomy. Neurosurgery 53:91-97, 2003.
2. Bayston R, Barnicoat M, Cudmore RE, Guiney EJ, Gurusinghe N, Norman PM: The use of intraventricular vancomycin in the treatment of CSF shunt-associated ventriculitis. Z Kinderchir 39 [Suppl 2]:111-113, 1984.
3. Bayston R, Penny SR: Excessive production of mucoid substance in staphylococcus SIIA: A possible factor in colonisation of Holter shunts. Dev Med Child Neurol Suppl 27:25-28, 1972.
4. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D: Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 85:495-498, 1988.
5. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D: Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53:127-129, 2004.
6. Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin North Am 4:633-656, 1993.
7. Czosnyka ZH, Czosnyka M, Pickard JD: Shunt testing in-vivo: a method based on the data from the UK shunt evaluation laboratory. Acta Neurochir Suppl 81:27-30, 2002.
8. Darouiche RO: Treatment of infections associated with surgical implants. N Engl J Med 350:1422-1429, 2004.
9. Drake JM, Sainte-Rose C: Cerebrospinal fluid shunt complications, in Drake JM, Sainte-Rose C: The Shunt Book. Cambridge, Blackwell Science, 1995, pp 121-192.
10. Drake JM, Sainte-Rose C: Cerebrospinal fluid shunt components, in Drake JM, Sainte-Rose C: The Shunt Book. Cambridge, Blackwell Science, 1995, pp 69-121.
11. Dugdale DC, Ramsey PG: Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 89:137-141, 1990.
12. Dunne WM Jr, Mason EO Jr, Kaplan SL: Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 37:2522-2526, 1993.
13. Edwards RJ, Pople IK: Endoscopic choroid plexus coagulation reduces proximal shunt catheter revision rates in non-tumoral hydrocephalus. J Neurosurg 98:682, 2003 (abstr).
14. Edwards RJ, Witchell C, Pople IK: Chronic headaches in adults with spina bifida and associated hydrocephalus. Eur J Pediatr Surg 1[13 Suppl]:S13-S17, 2003.
15. Elliott SP, Yogev R, Shulman ST: Staphylococcus lugdunensis: An emerging cause of ventriculoperitoneal shunt infections. Pediatr Neurosurg 35:128-130, 2001.
16. Elting LS, Bodey GP: Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections. Medicine (Baltimore) 69:296-306, 1990.
17. Fan-Havard P, Nahata MC, Bartkowski MH, Barson WJ, Kosnik EJ: Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy 36:103-108, 1990.
18. Frame PT, McLaurin RL: Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy. J Neurosurg 60:354-360, 1984.
19. Grabb PA, Albright AL: Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: Report of two patients. Neurosurgery 30:630-634, 1992.
20. Gump DW: Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 3:3289-3292, 1981.
21. James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA: Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 7:459-463, 1980.
22. Karchmer AW, Archer GL, Dismukes WE: Ritampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 3 [Suppl 5]:S543-S548, 1983.
23. Kaufman BA, Tunkel AR, Pryor JC, Dacey RG: Meningitis in the neurosurgical patient. Infect Dis Clin North Am 4:677-701, 1990.
24. Klein DM: Shunt infections, in Scott RM (ed): Hydrocephalus: Concepts in Neurosurgery. Baltimore, Williams and Wilkins, 1990, p 88.
25. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: A prospective study of risk factors. J Neurosurg 94:195-201, 2001.
26. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM: Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 35:66-71, 2001.
27. Leggate JR, Baxter P, Minns RA, Steers AJ, Brown JK, Shaw JF, Elton RA: Role of a separate subcutaneous cerebro-spinal fluid reservoir in the management of hydrocephalus. Br J Neurosurg 2:327-337, 1988.
28. Leggiadro RJ, Atluru VL, Katz SP: Meningococcal meningitis associated with cerebrospinal fluid shunts. Pediatr Infect Dis 3:489-490, 1984.
29. Lerman SJ: Haemophilus influenzae infections of cerebrospinal fluid shunts. Report of two cases. J Neurosurg 54:261-263, 1981.
30. McLaurin RL: Infected cerebrospinal fluid shunts. Surg Neurol 1:191-195, 1973.
31. McLaurin RL: Treatment of infected ventricular shunts. Childs Brain 1:306-310, 1975.
32. Monzon M, Oteiza C, Leiva J, Amorena B: Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 48:793-801, 2001.
33. Patriarca PA, Lauer BA: Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae. Pediatrics 65:1007-1009, 1980.
34. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: A study of etiological factors. J Neurosurg 77:29-36, 1992.
35. Pople IK, Edwards RJ, Aquilina K: Endoscopic methods of hydrocephalus treatment. Neurosurg Clin North Am 12:719-735, 2001.
36. Schreffler RT, Schreffler AJ, Wittler RR: Treatment of cerebrospinal fluid shunt infections: A decision analysis. Pediatr Infect Dis J 21:632-636, 2002.
37. Shurtleff DB, Foltz EL, Weeks RD, Loeser J: Therapy of Staphylococcus epidermidis: Infections associated with cerebrospinal fluid shunts. Pediatrics 53:55-62, 1974.
38. Taylor D, Prosser B, Cleeland R: Activity of antimicrobial agents against Staphylococcus epidermidis in established biofilms on latex catheter material and on titanium. J Antimicrob Chemother 21:510-512, 1988.
39. von Eiff C, Peters G, Heilmann C: Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677-685, 2002.
40. Waghorn DJ: Intravascular device-associated systemic infections: A 2 year analysis of cases in a district general hospital. J Hosp Infect 28:91-101, 1994.
41. Walters IN, Teychenne PF, Claveria LE, Calne DB: Penicillin transport from cerebrospinal fluid. Neurology 26:1008-1010, 1976.
42. Whitehead WE, Kestle JR: The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 35:205-210, 2001.
43. Widmer AF, Frei R, Rajacic Z, Zimmerli W: Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162:96-102, 1990.
44. Yogev R: Cerebrospinal fluid shunt infections: A personal view. Pediatr Infect Dis 4:113-118, 1985.
45. Yogev R, Davis AT: Neurosurgical shunt infections. A review. Childs Brain 6:74-81, 1980.
46. Younger JJ, Christensen GD, Bartley DL, Simmons JC, Barrett FF: Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: Importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis 156:548-554, 1987.
47. Zimmerli W, Frei R, Widmer AF, Rajacic Z: Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33:959-967, 1994.